Works matching DE "ROSIGLITAZONE"

Results: 702

Improvement of Insulin Sensitivity by a Novel Drug Candidate, BGP-15, in Different Animal Studies.

Published in:

Metabolic Syndrome & Related Disorders, 2014, v. 12, n. 2, p. 125, doi. 10.1089/met.2013.0098

By:

Literáti-Nagy, Botond;
Tory, Kálmán;
Peitl, Barna;
Bajza, Ágnes;
Korányi, László;
Literáti-Nagy, Zsuzsanna;
Hooper, Philip L.;
Vígh, László;
Szilvássy, Zoltán

Publication type:

Article

Obestatin and Rosiglitazone Differentially Modulate Lipid Metabolism Through Peroxisome Proliferator-activated Receptor-γ (PPARγ) in Pre-adipose and Mature 3T3-L1 Cells.

Published in:

Cell Biochemistry & Biophysics, 2021, v. 79, n. 1, p. 73, doi. 10.1007/s12013-020-00958-7

By:

B. G., Mallikarjuna;
Manjappara, Uma V.

Publication type:

Article

Inverse association of PPARγ agonists use and high grade glioma development.

Published in:

Journal of Neuro-Oncology, 2010, v. 100, n. 2, p. 233, doi. 10.1007/s11060-010-0185-x

By:

Grommes, Christian;
Conway, Devon;
Alshekhlee, Amer;
Barnholtz-Sloan, Jill

Publication type:

Article

Thiazolidinedione Drugs Promote Onset, Alter Characteristics, and Increase Mortality of Ischemic Ventricular Fibrillation in Pigs.

Published in:

Cardiovascular Drugs & Therapy, 2012, v. 26, n. 3, p. 195, doi. 10.1007/s10557-012-6384-2

By:

Sarraf, Mohammad;
Lu, Li;
Ye, Shuyu;
Reiter, Michael;
Greyson, Clifford;
Schwartz, Gregory

Publication type:

Article

Rosiglitazone enhances radiosensitivity by inhibiting repair of DNA damage in cervical cancer cells.

Published in:

Radiation & Environmental Biophysics, 2017, v. 56, n. 1, p. 89, doi. 10.1007/s00411-016-0679-9

By:

An, Zhengzhe;
Yu, Jae-Ran;
Park, Woo-Yoon

Publication type:

Article

A New Co-Crystal of Synthetic Drug Rosiglitazone with Natural Medicine Berberine: Preparation, Crystal Structures, and Dissolution.

Published in:

Molecules, 2020, v. 25, n. 18, p. 4288, doi. 10.3390/molecules25184288

By:

Guan, Xiaoshu;
Jiang, Lan;
Cai, Linhong;
Zhang, Li;
Hu, Xiangnan

Publication type:

Article

The PPARγ Agonist Rosiglitazone Suppresses Syngeneic Mouse SCC (Squamous Cell Carcinoma) Tumor Growth through an Immune-Mediated Mechanism.

Published in:

Molecules, 2019, v. 24, n. 11, p. 2192, doi. 10.3390/molecules24112192

By:

Konger, Raymond L.;
Derr-Yellin, Ethel;
Ermatov, Nurmukambed;
Ren, Lu;
Sahu, Ravi P.;
Capasso, Raffaele;
Iannotti, Fabio Arturo

Publication type:

Article

The Rosiglitazone-Like Effects of Vitexilactone, a Constituent from Vitex trifolia L. in 3T3-L1 Preadipocytes.

Published in:

Molecules, 2017, v. 22, n. 11, p. 2030, doi. 10.3390/molecules22112030

By:

Atsuyoshi Nishina;
Masaya Itagaki;
Daisuke Sato;
Hirokazu Kimura;
Yasuaki Hirai;
Nyunt Phay;
Makoto Makishima

Publication type:

Article

Protective Effects of Red Guava on Inflammation and Oxidative Stress in Streptozotocin-Induced Diabetic Mice.

Published in:

Molecules, 2015, v. 20, n. 12, p. 22341, doi. 10.3390/molecules201219831

By:

Pei-Ying Li;
Cheng-Chin Hsu;
Mei-Chin Yin;
Yueh-Hsiung Kuo;
Feng-Yao Tang;
Che-Yi Chao

Publication type:

Article

Rosiglitazone Inhibits Angiotensin IIInduced Proliferation of Glomerular Mesangial Cells via the Gαq/Plcβ4/TRPC Signaling Pathway.

Published in:

Cellular Physiology & Biochemistry (Karger AG), 2017, v. 44, n. 6, p. 2228, doi. 10.1159/000486056

By:

Wei, Linting;
Mao, Jiarong;
Lu, Jiamei;
Gao, Jie;
Zhu, Dan;
Tian, Lifang;
Chen, Zhao;
Jia, Lining;
Wang, Li;
Fu, Rongguo

Publication type:

Article

Rosiglitazone Promotes AQP2 Plasma Membrane Expression In Renal Cells Via a Ca-Dependent/cAMP-Independent Mechanism.

Published in:

Cellular Physiology & Biochemistry (Karger AG), 2015, v. 35, n. 3, p. 1070, doi. 10.1159/000373933

By:

Procino, Giuseppe;
Gerbino, Andrea;
Milano, Serena;
Nicoletti, Maria Celeste;
Mastrofrancesco, Lisa;
Carmosino, Monica;
Svelto, Maria

Publication type:

Article

PPARγ-Induced Stimulation of Amiloride-Sensitive Sodium Current in Renal Collecting Duct Principal Cells is Serum and Insulin Dependent.

Published in:

Cellular Physiology & Biochemistry (Karger AG), 2014, v. 33, n. 3, p. 581, doi. 10.1159/000358636

By:

Chraïbi, Ahmed;
Renauld, Stéphane

Publication type:

Article

Niche oral agents in type 2 diabetes.

Published in:

Medicine Today, 2021, v. 22, n. 10, p. 29

By:

JALLEH, RYAN;
STRANKS, STEPHEN

Publication type:

Article

Making a case for rosiglitazone.

Published in:

2011

By:

Feeman Jr, W. E.

Publication type:

Letter

Is your patient still using rosiglitazone?

Published in:

2011

By:

Gov-Ari, Hanna K.;
Stevermer, James J.

Publication type:

journal article

Expression of Concern on “The Novel Oral Drug Subetta Exerts an Antidiabetic Effect in the Diabetic Goto-Kakizaki Rat: Comparison with Rosiglitazone”.

Published in:: Journal of Diabetes Research, 2019, p. 1, doi. 10.1155/2019/2938413
Publication type:: Article

Rosiglitazone Elicits an Adiponectin-Mediated Insulin-Sensitizing Action at the Adipose Tissue-Liver Axis in Otsuka Long-Evans Tokushima Fatty Rats.

Published in:

Journal of Diabetes Research, 2018, p. 1, doi. 10.1155/2018/4627842

By:

Li, Jia;
Xue, Yao-Ming;
Zhu, Bo;
Pan, Yong-Hua;
Zhang, Yan;
Wang, Chunxia;
Li, Yuhao

Publication type:

Article

Evaluation of the Drug–Drug Interaction Potential of Acalabrutinib and Its Active Metabolite, ACP‐5862, Using a Physiologically‐Based Pharmacokinetic Modeling Approach.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2019, v. 8, n. 7, p. 489, doi. 10.1002/psp4.12408

By:

Zhou, Diansong;
Podoll, Terry;
Xu, Yan;
Moorthy, Ganesh;
Vishwanathan, Karthick;
Ware, Joseph;
Slatter, J. Greg;
Al‐Huniti, Nidal

Publication type:

Article

Rosiglitazone disrupts pancreatic ductal adenocarcinoma progression by activating the tumor suppressor ESE3/EHF.

Published in:

Cancer Biology & Medicine, 2022, v. 19, n. 7, p. 945, doi. 10.20892/j.issn.2095-3941.2022.0299

By:

Hongquan Wang;
Shuang Wu;
Yan Wang;
Bo Tang

Publication type:

Article

A variant of PSMD6 is associated with the therapeutic efficacy of oral antidiabetic drugs in Chinese type 2 diabetes patients.

Published in:

Scientific Reports, 2015, p. 10701, doi. 10.1038/srep10701

By:

Chen, Miao;
Zhang, Rong;
Jiang, Feng;
Wang, Jie;
Peng, Danfeng;
Tang, Shanshan;
Sun, Xue;
Yan, Jing;
Wang, Shiyun;
Wang, Tao;
Bao, Yuqian;
Jia, Weiping;
Hu, Cheng

Publication type:

Article

Identification of a novel selective agonist of PPARγ with no promotion of adipogenesis and less inhibition of osteoblastogenesis.

Published in:

Scientific Reports, 2015, p. 9530, doi. 10.1038/srep09530

By:

Liu, Chang;
Feng, Tingting;
Zhu, Ningyu;
Liu, Peng;
Han, Xiaowan;
Chen, Minghua;
Wang, Xiao;
Li, Ni;
Li, Yongzhen;
Xu, Yanni;
Si, Shuyi

Publication type:

Article

Determination of Pka Values of Antidiabetic Drugs from Mobility Data and Pharmaceutical Analysis by Capillary Electrophoresis.

Published in:

Journal of the Chemical Society of Pakistan, 2022, v. 44, n. 4, p. 366, doi. 10.52568/001068/jcsp/44.04.2022

By:

Sanli, Senem;
Sardogan, Seyfi;
Özdemir, Ayse;
Atalay, Baris

Publication type:

Article

Protective influence of rosiglitazone against testicular ischaemia–reperfusion injury in rats.

Published in:

Andrologia, 2018, v. 50, n. 4, p. 1, doi. 10.1111/and.12947

By:

Zheng, N.;
Shao, H.;
Wu, D.;
Shen, D.;
Lin, X.

Publication type:

Article

Expression of p-PPARγ in the aging thoracic aorta of spontaneously hypertensive rat and inhibitory effect of rosiglitazone.

Published in:

Asian Pacific Journal of Tropical Biomedicine, 2014, v. 4, n. 12, p. 977, doi. 10.12980/APJTB.4.201414B416

By:

Yuan, Hai-Feng;
Niu, Xiao-Lin;
Gao, Deng-Feng;
Hao, Guang-Hua;
Song, An-Qi;
Wei, Jin

Publication type:

Article

Formulation and evaluation of floating tablet of rosiglitazone malate.

Published in:

International Journal of Pharmacy & Life Sciences, 2012, v. 3, n. 2, p. 1475

By:

Singh, Koushlendra;
Dhakar, Virendra Kumar;
Rai, Vishnu Kant

Publication type:

Article

Can Metformin or Rosiglitazone Reduce Metabolic Side Effects Associated with Atypical Antipsychotics?

Published in:

Issues in Mental Health Nursing, 2009, v. 30, n. 12, p. 803, doi. 10.3109/01612840903276712

By:

Housel, Audrey K.;
Waterbury, Nancee;
Argo, Tami R.;
Roman, Marian

Publication type:

Article

Rosiglitazone and fenofibrate additive effects on lipids.

Published in:

2011

By:

Slim, Ahmad;
Castillo-Rojas, Laudino;
Hulten, Eddie;
Slim, Jennifer N.;
Moore, Dorette Pearce;
Villines, Todd C.;
Pearce Moore, Dorette

Publication type:

journal article

Impact of Sex on the Therapeutic Efficacy of Rosiglitazone in Modulating White Adipose Tissue Function and Insulin Sensitivity.

Published in:

Nutrients, 2024, v. 16, n. 18, p. 3063, doi. 10.3390/nu16183063

By:

Bauzá-Thorbrügge, Marco;
Amengual-Cladera, Emilia;
Galmés-Pascual, Bel Maria;
Morán-Costoya, Andrea;
Gianotti, Magdalena;
Valle, Adamo;
Proenza, Ana Maria;
Lladó, Isabel

Publication type:

Article

Simultaneous determination of Nitazoxanide and Ofloxacin in pharmaceutical preparations using UV-spectrophotometric and high performance thin layer chromatography methods.

Published in:

Arabian Journal of Chemistry, 2017, v. 10, p. S62, doi. 10.1016/j.arabjc.2012.07.009

By:

Sharma, Smita;
Sharma, Mukesh C.;
Sahu, Nitendra K.

Publication type:

Article

Electrochemical determination of rosiglitazone by square-wave adsorptive stripping voltammetry method

Published in:

Arabian Journal of Chemistry, 2012, v. 5, n. 3, p. 383, doi. 10.1016/j.arabjc.2011.07.011

By:

Al-Ghamdi, Ali F.;
Hefnawy, Mohamed M.

Publication type:

Article

Meta-analysis of rare adverse events in randomized clinical trials: Bayesian and frequentist methods.

Published in:

Clinical Trials, 2021, v. 18, n. 1, p. 3, doi. 10.1177/1740774520969136

By:

Hong, Hwanhee;
Wang, Chenguang;
Rosner, Gary L

Publication type:

Article

Rosiglitazone Inhibits HMC-1 Cell Migration and Adhesion through a Peroxisome Proliferator-Activated Receptor Gamma-Dependent Mechanism.

Published in:

Iranian Journal of Allergy, Asthma & Immunology, 2014, v. 13, n. 1, p. 11

By:

Guqin Zhang;
Jiong Yang;
Ping Li;
Jie Cao;
Hanxiang Nie

Publication type:

Article

MitoToxy assay: A novel cell-based method for the assessment of metabolic toxicity in a multiwell plate format using a lactate FRET nanosensor, Laconic.

Published in:

PLoS ONE, 2019, v. 14, n. 10, p. 1, doi. 10.1371/journal.pone.0224527

By:

Contreras-Baeza, Yasna;
Ceballo, Sebastián;
Arce-Molina, Robinson;
Sandoval, Pamela Y.;
Alegría, Karin;
Barros, Luis Felipe;
San Martín, Alejandro

Publication type:

Article

Rosiglitazone in the thawing medium improves mitochondrial function in stallion spermatozoa through regulating Akt phosphorylation and reduction of caspase 3.

Published in:

PLoS ONE, 2019, v. 14, n. 7, p. 1, doi. 10.1371/journal.pone.0211994

By:

Ortiz-Rodriguez, José M.;
Balao da Silva, Carolina;
Masot, Javier;
Redondo, Eloy;
Gazquez, Antonio;
Tapia, José A.;
Gil, Cruz;
Ortega-Ferrusola, Cristina;
Peña, Fernando J.

Publication type:

Article

Development and Validation of RP-HPLC Method for Simultaneous Determination of Glipizide, Rosiglitazone, Pioglitazone, Glibenclamide and Glimepiride in Pharmaceutical Dosage Forms and Human Plasma.

Published in:: Journal of the Iranian Chemical Society, 2011, v. 8, n. 1, p. 31, doi. 10.1007/BF03246199
Publication type:: Article

Pioglitazone reduces inflammation through inhibition of NF-κB in polymicrobial sepsis.

Published in:

Innate Immunity, 2014, v. 20, n. 5, p. 519, doi. 10.1177/1753425913501565

By:

Kaplan, Jennifer;
Nowell, Marchele;
Chima, Ranjit;
Zingarelli, Basilia

Publication type:

Article

Activation of peroxisome proliferator-activated receptor-γ potentiates pro-inflammatory cytokine production, and adrenal and somatotropic changes of weaned pigs after Escherichia coli lipopolysaccharide challenge.

Published in:

Innate Immunity, 2009, v. 15, n. 3, p. 169, doi. 10.1177/1753425908102014

By:

Yulan Liu;
Junxia Shi;
Jing Lu;
Guoquan Meng;
Huiling Zhu;
Yongqing Hou;
Yulong Yin;
Shengjun Zhao;
Binying Ding

Publication type:

Article

Anti-ageing effects of FDA-approved medicines: a focused review.

Published in:

Journal of Basic & Clinical Physiology & Pharmacology, 2023, v. 34, n. 3, p. 277, doi. 10.1515/jbcpp-2022-0242

By:

Thanapairoje, Koranit;
Junsiritrakhoon, Supanut;
Wichaiyo, Surasak;
Osman, Mohd Azuraidi;
Supharattanasitthi, Wasu

Publication type:

Article

Phase 1 safety and pharmacokinetic study on the use of pioglitazone in critically ill patients with sepsis: a randomized clinical trial.

Published in:

2018

By:

Kaplan, Jennifer M.;
Zingarelli, Basilia;
Krallman, Kelli;
Tang Girdwood, Sonya;
Lagory, Denise;
Mizuno, Tomoyuki;
Fei, Lin;
Wong, Hector R.;
Vinks, Alexander A.

Publication type:

clinical trial

Topical rosiglitazone treatment improves ulcerative colitis by restoring peroxisome proliferator-activated receptor-gamma activity.

Published in:: Inflammatory Bowel Disease Monitor, 2010, v. 11, n. 2, p. 82
Publication type:: Article

Rosiglitazone Suppresses Glioma Cell Growth and Cell Cycle by Blocking the Transforming Growth Factor-Beta Mediated Pathway.

Published in:

Neurochemical Research, 2012, v. 37, n. 10, p. 2076, doi. 10.1007/s11064-012-0828-8

By:

Wang, Peng;
Yu, Jinpu;
Yin, Qiang;
Li, Wenliang;
Ren, Xiubao;
Hao, Xishan

Publication type:

Article

Preventive effect of rosiglitazone on liver injury in a mouse model of decompression sickness.

Published in:

Diving & Hyperbaric Medicine: Journal of the South Pacific Underwater Medicine Society, 2017, v. 47, n. 1, p. 17, doi. 10.28920/dhm47.1.17-23.PMID28357820

By:

Bin Peng;
Miao-Miao Chen;
Zheng-Lin Jiang;
Xia Li;
Guo-Hua Wang;
Li-Hua Xu

Publication type:

Article

Activation of Peroxisome Proliferator-Activated Receptor γ by Rosiglitazone Inhibits Lipopolysaccharide-Induced Release of High Mobility Group Box 1.

Published in:

Mediators of Inflammation, 2012, v. 2012, p. 1, doi. 10.1155/2012/352807

By:

Jung Seok Hwang;
Eun Sil Kang;
Sun Ah Ham;
Taesik Yoo;
Hanna Lee;
Kyung Shin Paek;
Chankyu Park;
Jin-Hoi Kim;
Dae-Seog Lim;
Han Geuk Seo

Publication type:

Article

Quantitative Histopathological Assessment of Retardation of Islets of Langerhans Degeneration in Rosiglitazone-dosed Obese ZDF Rats Using Combined Insulin and Collagens (I and III) Immunohistochemistry with Automated Image Analysis and Statistical ...

Published in:

Toxicologic Pathology, 2013, v. 41, n. 3, p. 425, doi. 10.1177/0192623312460923

By:

Jones, Huw B.;
Bigley, Alison L.;
Pemberton, John;
Randall, Kevin J.

Publication type:

Article

Distinct Functions of Vascular Endothelial and Smooth Muscle PPARγ in Regulation of Blood Pressure and Vascular Tone.

Published in:

Toxicologic Pathology, 2009, v. 37, n. 1, p. 4, doi. 10.1177/0192623308328545

By:

Ningning Wang;
Symons, J. David;
Hui Zhang;
Zhanjun Jia;
Gonzalez, Frank J.;
Tianxin Yang

Publication type:

Article

Effects of Rosiglitazone with Insulin Combination Therapy on Oxidative Stress and Lipid Profile in Left Ventricular Muscles of Diabetic Rats.

Published in:

Experimental Diabetes Research, 2012, p. 1, doi. 10.1155/2012/905683

By:

Kavak, Servet;
Ayaz, Lokman;
Emre, Mustafa

Publication type:

Article

Rosiglitazone Prevents High Glucose-Induced Vascular Endothelial Growth Factor and Collagen IV Expression in Cultured Mesangial Cells.

Published in:

Experimental Diabetes Research, 2009, p. 1, doi. 10.1155/2009/910783

By:

Whiteside, Catharine;
Hong Wang;
Ling Xia;
Munk, Snezana;
Goldberg, Howard J.;
Fantus, I. George

Publication type:

Article

Spectrophotometric Determination of Poorly Water Soluble Drug Rosiglitazone Using Hydrotropic Solubilization technique.

Published in:

Indian Journal of Pharmaceutical Sciences, 2011, v. 73, n. 5, p. 579, doi. 10.4103/0250-474X.99021

By:

Sherje, A. P.;
Desai, K. J.

Publication type:

Article

Validated High Performance Thin Layer Chromatographic Determination and Content Uniformity Test for Rosiglitazone in Tablets.

Published in:

Indian Journal of Pharmaceutical Sciences, 2010, v. 72, n. 2, p. 249, doi. 10.4103/0250-474X.65034

By:

WALODE, S. G.;
CHAUDHARI, H. K.;
SARASWAT, M. S.;
KASTURE, A. V.;
WADODKAR, S. G.

Publication type:

Article

Acute fulminant hepatic failure associated with the use of rosiglitazone.

Published in:

2003

By:

Kessler, William;
Johnson, Ben;
Yoo, Hwan Y

Publication type:

Abstract